| Date | Title | Description |
| 13.05.2021 | UK’s healthtech startup Huma raises €107.5M to scale its digital ‘hospitals at home’ platform | The UK-based healthtech startup Medopad that rebranded to Huma back in April 2020 is on a mission to go beyond remote patient monitoring and into digital biomarkers and therapeutics. In a recent development, the healthtech company announced... |
| 13.05.2021 | Huma Therapeutics pulls in $130M Series C | Digital health startup Huma Therapeutics has raised around $130 million in a round led by Leaps by Bayer and Hitachi Ventures. The company's software lets clinicians monitor patients remotely through its mobile app. The Series C includes an... |
| 12.05.2021 | London’s predictive healthcare and research platform Huma raises $130 million in Series C round | London-based Huma Therapeutics has closed a Series C funding round at $130 million. Led by Leaps by Bayer and Hitachi Ventures, Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures, and HAT Technology & Innovation Fund by HAT, a... |
| 12.05.2021 | Healthtech AI start-up Medopad raises $28m Series A | Medopad, a London-headquartered AI healthtech business, has raised $28m worth of Series A finance in a funding round led by China’s NWS Holdings.
Looking to raise $120m over the coming months, the latest installment of funding will help Med... |
| 11.05.2021 | Huma raises $130 million financing to scale its digital health platform for better care and research
USA - English USA - English USA - English | |
| 11.05.2021 | Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M | While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19, one of the companies that has been helping to manage the spread of the virus is announcing a big round of funding on the... |
| 15.04.2020 | Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform | Some big changes are underway for London-based Medopad, a startup that builds software for medical practitioners to monitor patients remotely based on digital biomarkers — measurable indicators of the progression of illnesses, diseases or o... |
| 05.11.2019 | Medopad raises $25M led by Bayer to develop biomarkers tracked via apps and wearables | Medopad, the U.K. startup that has been working with Tencent to develop AI-based methods for building and tracking “digital” biomarkers — measurable indicators of the progression of illnesses and diseases that are picked up not with blood s... |
| 05.11.2019 | Medopad raises $25 million to detect chronic diseases using AI and big data | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Medopad, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic dis... |
| 05.11.2019 | Data collection, analysis tool Medopad scores $25M in Series B funding | |
| 05.11.2019 | UK-based healthtech startup Medopad raises €22.5M in Series B investment led by Leaps by Bayers | New age health startups are all the rage right now and rightly so since they are introducing new ways to better our health and lives. By leveraging some of the cutting edge technologies available, many medtech startups have already made a n... |
| 05.11.2019 | Medopad raises $25 million to detect chronic diseases using AI and big data | Medopad, a U.K.-based health technology startup that uses machine learning and big data analyses to help predict and manage chronic diseases, has raised $25 million in a series B round of funding led by Leaps by Bayer, the VC arm of German ... |
| 21.12.2018 | IBM researchers monitor Parkinson’s disease with fingernail sensors | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Grip strength can reveal a lot about a person — including whether a neurodegenerative disease is about to set in and how far it has pro... |
| 08.10.2018 | Tencent partners with Medopad to improve Parkinson’s disease treatment with AI | Roughly 600,000 people in the U.S. are diagnosed with Parkinson’s every year, contributing to the more than 10 million people worldwide already living with the neurodegenerative disease. Early detection can result in significantly better tr... |
| 08.10.2018 | Tencent partners with Medopad to improve Parkinson’s disease treatment with AI | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Roughly 600,000 people in the U.S. are diagnosed with Parkinson’s every year, contributing to the more than 10 million people worldwide... |
| 11.09.2018 | Top tech startup news stories you need to know this Tuesday, September 11 | Good morning! Here are some of the top tech startup news stories for today, Tuesday, September 11.
Medical device and artificial intelligence startup AliveCor becomes the first company to receive FDA-clearance to use heart signals to detec... |
| 11.09.2018 | Medopad acquires U.S. rival Sherbit for AI-driven disease detection | Medopad, a U.K. health technology startup that leverages machine learning to connect patients with a range of health care professionals, has announced its expansion into the U.S. with its acquisition of San Francisco-based Sherbit.
Founded ... |
| 11.09.2018 | UK-based healthtech company Medopad acquired Sherbit as part of its US expansion | Medopad, the UK-based healthtech company that develops applications to connect patients with medical professionals, has acquired a Silicon Valley startup Sherbit for an undisclosed amount. Earlier in 2018, Medopad also opened offices in New... |
| 11.09.2018 | Medopad acquires U.S. rival Sherbit for AI-driven disease detection | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Medopad, a U.K. health technology startup that leverages machine learning to connect patients with a range of health care professionals... |
| 07.02.2018 | China’s NWS backs $28m funding in UK health-tech startup Medopad | Premium
British health tech AI start-up Medopad raised $28 million in a Series A funding round backed by Hong Kong-listed conglomerate NWS Holdings Limited (NWS) and a number of global family offices and institutional investors, the company... |
| 05.02.2018 | Term Sheet — Monday, February 5 | 2 DEALS & A BANKRUPTCY
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
The transaction comes at a time when PE firms are under growing pressure to deploy the record amount of capital they... |
| 02.02.2018 | Health tech startup Medopad raises $28 million from Chinese investors | UK digital health startup Medopad has announced $28 million in funding led by China’s NWS Holdings, with a view to raising $120 million in total for the Series A round.
Medopad is a platform for data capture and improving communication betw... |
| 02.02.2018 | Medopad Secures US$26M in First Close of Series A Funding | Medopad, a London, UK-based healthtech AI company, secured US$26m in the first close of its Series A funding.
Backers included a number of global family offices and institutional investors including China’s NWS Holdings (Hong Kong stock cod... |
| 02.02.2018 | Healthtech AI start-up Medopad raises $28m Series A | Medopad, a London-headquartered AI healthtech business, has raised $28m worth of Series A finance in a funding round led by China’s NWS Holdings.
Looking to raise $120m over the coming months, the latest installment of funding will help Med... |
| 20.02.2017 | How Social Causes Are Driving Tech Sector Innovation | Today, ethical and sustainable products are king. Nearly three-fourths of Millennials, the demographic piloting this movement, are willing to pay more for sustainable products, according to a recent Nielsen study. Another 91 percent will sw... |
| - | Healthtech AI start-up Medopad raises $28m Series A | Medopad, a London-headquartered AI healthtech business, has raised $28m worth of Series A finance in a funding round led by China’s NWS Holdings.
Looking to raise $120m over the coming months, the latest installment of funding will help Med... |
